Delivery Order SPE2DB24D2013-SPE2DB24FCHBR
Award Date
6/25/24
Potential Completion Date
6/26/24
Potential Value
$7.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,493.27 firm fixed-price delivery order is for the supply of LAMICTAL XR 200 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of January 30, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $12,327.66 under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The award, which has an ultimate completion date of October 23, 2024, is for the supply of LAMICTAL XR 300 MG TABLET 30S, a pharmaceutical product. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,834.90 firm fixed-price delivery order is for the supply of LAMICTAL XR 100 MG TABLET 30S. The contract has an ultimate completion date of May 10, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,474.07 firm fixed-price delivery order is for LAMICTAL XR 250 MG TABLET 30S, a mental health medication, with a completion date of December 12, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,402.14 firm fixed-price delivery order is for the supply of LAMICTAL XR 100 MG TABLET 30S, a prescription medication. The contract has an ultimate completion date of December 21, 2023 and was awarded on December 20, 2023. There is no set-aside designation noted. AmerisourceBergen holds a $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,863.24 firm fixed-price delivery order contract is for the supply of LAMICTAL XR 25 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of February 6, 2025. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This federal contract award, valued at $5,259.97, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of February 21, 2025. The contract covers the procurement of LAMICTAL XR 300 MG TABLET 30S, a pharmaceutical product used in the treatment of various medical conditions. Amerisourcebergen...
This federal contract award, with ID SPE2DB22D1106|SPE2DB24FEVY7, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LAMICTAL XR 100 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $6,470.46 and a completion date of June 10, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $5,668.16, is for the delivery of LAMICTAL XR 25 MG TABLET 30S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order, with a period of performance through June 24, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division is a Delivery Order valued at $4,268.57 for the supply of LAMICTAL XR 200 MG TABLET 30S. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a significant customer of Amerisourcebergen. This award is placed against Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which...